CoChat

Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform

Kolaj, Igri, Imindu Liyanage, S., Weaver, Donald F. · 2018 · Neurochemistry International
Cited by 39

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

Abstract

&NA; Alzheimer's disease (AD) is a neurodegenerative disorder, characterized by progressive dementia, neuroinflammation and the accumulation of intracellular neurofibrillary tangles and extracellular plaques. The etiology of AD is unclear, but is generally attributed to four leading hypotheses: (i) abnormal folding and aggregation of amyloid‐&bgr; (A&bgr;)/tau proteins (ii) activation of the innate immune system, (iii) mitochondrial dysfunction, and (iv) oxidative stress. To date, therapeutic strategies have largely focused on A&bgr;‐centric targets; however, the repeated failure of clinical trials and the continued lack of a disease‐modifying therapy demand novel, multifaceted approaches. Natural products are common molecular platforms in drug development; in AD, compounds from the plant phenylpropanoid metabolic pathway have yielded promising associations. Herein, we review developments in the pathogenesis of AD and the metabolism of phenylpropanoids in plants. We further discuss the role of these metabolites as relevant to the four leading mechanisms of AD pathogenesis, and observe multiple protective effects among phenylpropanoids against AD onset and progression. HighlightsAlzheimer's disease (AD) originates from multiple intertwined mechanisms.Phenylpropanoids are plant metabolites with a variety of bioactive interactions.Their effect on A&bgr;/tau, inflammation, oxidative stress & mitochondria are reviewed.Phenylpropanoids may be a promising candidate for therapeutic intervention in AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.neuint.2018.08.001

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 39

Metadata

Authors
Kolaj, I., Imindu Liyanage, S., & Weaver, D. F.
Venue
Neurochemistry International
Publisher
Elsevier BV
Published
2018-11
Volume
120
Pages
99-111
ISSN
0197-0186 (ISSN-L)
OpenAlex
W2887009692
Cited by
39
References
46
FWCI
2.52
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform. https://app.cochat.ai/papers/10.1016/j.neuint.2018.08.001
The paper
Kolaj, I., Imindu Liyanage, S., & Weaver, D. F. (2018). Phenylpropanoids and Alzheimer's disease: A potential therapeutic platform. Neurochemistry International. https://doi.org/10.1016/j.neuint.2018.08.001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.